MedTrace Logo

Video Game-based Physical Activity Training in People With Multiple Sclerosis During Relapse Treatment

NCT04125823 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-06-01

No results posted yet for this study

Summary

The study aims to investigate the feasibility and acceptability of the video game-based physical activity training program in the inpatient period during relapse treatment. The secondary aims are to investigate its effectiveness on upper extremity functions, walking, balance, cognitive functions, quality of life, depression, and fatigue comparing to conventional rehabilitation in persons with multiple sclerosis.

Conditions

Interventions

BEHAVIORAL

Video game-based physical activity training

Based on the physical levels of the patients, appropriate games will be selected and video game based physical activity training will be started. Video games will be played with Xbox One with a motion sensor (Microsoft) and a 52'' Liquid Crystal Display. Depending on the prognosis of the patients, the grades and types of games will be changed. Sessions will be performed by a physiotherapist for 45 minutes once a day during the hospital stay.

BEHAVIORAL

Conventional physiotherapy program

A conventional physiotherapy program including balance, upper extremity, and core stabilization exercises will be implemented. Sessions will be performed by a physiotherapist for 45 minutes once a day during the hospital stay.

Sponsors & Collaborators

  • Dokuz Eylul University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-23
Primary Completion
2022-01-15
Completion
2022-02-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04125823 on ClinicalTrials.gov